886: efficacy and safety of combination induction therapy with guselkumab and golimumab in patients with moderately-to-severely active ulcerative colitis: results through week 12 of the phase 2a vega study
GASTROENTEROLOGY（2022）
关键词
colitis,golimumab,combination induction therapy,guselkumab,moderately-to-severely
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要